• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺特异性抗原:一种新的前列腺标志物。是助力还是增加混淆因素?]

[PSA: a new prostatic marker. A help or an added factor of confusion?].

作者信息

Huber P R, Wisard M, Schmid H P

机构信息

Hormonlaboratorien, Frauenspital, Université de Bâle, Suisse.

出版信息

Ann Urol (Paris). 1994;28(4):235-7.

PMID:7526773
Abstract

In patients with a normal digital rectal examination and serum PSA levels under 18.4 ng/ml Yang (i.e. under 10.0 ng/ml Hybritech or under 14.4 ng.ml with the Basel Cantonal Hospital assay), twice yearly then yearly follow-up examinations are sufficient. More closely spaced examinations and a transrectal ultrasound scan are appropriate in patients with abnormalities upon digital rectal examination, especially when serum PSA levels are consistently elevated.

摘要

对于直肠指检正常且血清前列腺特异性抗原(PSA)水平低于18.4 ng/ml(即低于Hybritech检测法的10.0 ng/ml或巴塞尔州立医院检测法的14.4 ng/ml)的患者,每年进行两次随访检查,之后每年检查一次就足够了。对于直肠指检有异常的患者,尤其是血清PSA水平持续升高的患者,应进行间隔更短的检查并进行经直肠超声扫描。

相似文献

1
[PSA: a new prostatic marker. A help or an added factor of confusion?].[前列腺特异性抗原:一种新的前列腺标志物。是助力还是增加混淆因素?]
Ann Urol (Paris). 1994;28(4):235-7.
2
[Role of rectal exploration, suprapubic and transrectal prostatic ultrasonography, and PSA in the diagnosis and follow-up of prostatic carcinoma].[直肠指诊、耻骨上及经直肠前列腺超声检查以及前列腺特异性抗原在前列腺癌诊断及随访中的作用]
Minerva Med. 1998 Jul-Aug;89(7-8):267-75.
3
Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.前列腺癌的诊断:血清前列腺特异性抗原、直肠指检及经直肠超声检查的诊断价值
J Urol. 1994 Nov;152(5 Pt 1):1520-5. doi: 10.1016/s0022-5347(17)32460-6.
4
[Yield of transrectal ultrasonography in the diagnosis of prostatic cancer in symptomatic patients with normal rectal digital test].
Actas Urol Esp. 1997 Jun;21(6):565-71.
5
Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.前列腺特异性抗原和前列腺特异性抗原密度在检测不可触及的前列腺T1C期癌中的前瞻性评估。
J Urol. 1996 Nov;156(5):1685-90.
6
[The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].[经超声估计的前列腺特异性抗原绝对值及“密度”在疑似前列腺癌患者活检选择中的作用。95例接受超声引导下经直肠前列腺活检患者的前列腺特异性抗原(PSA)、触诊及超声检查结果比较]
Radiol Med. 1993 Jan-Feb;85(1-2):84-9.
7
Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.前列腺特异性抗原范围在3至3.9纳克/毫升之间的前列腺癌筛查:直肠指检与游离前列腺特异性抗原作为补充筛查试验的比较
J Urol. 2001 Oct;166(4):1339-42.
8
Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.游离前列腺特异性抗原百分比和前列腺特异性抗原密度作为提高前列腺特异性抗原在直肠指检正常且前列腺特异性抗原水平在4.1至10 ng/ml之间的男性早期前列腺癌检测中特异性的方法的比较
J Urol. 1997 Aug;158(2):502-4.
9
[Early diagnosis of prostatic cancer with digital rectal examination, PSA determination, and endorectal echography. Correlations with the morphologic diagnosis in 200 consecutive cases].[通过直肠指检、前列腺特异性抗原(PSA)测定及直肠内超声检查对前列腺癌进行早期诊断。200例连续病例与形态学诊断的相关性]
Prog Urol. 1992 Dec;2(6):973-9.
10
[Diagnosis of cancer of the prostate by determining the blood levels of specific prostatic antigen, rectal examination, and transrectal echography].通过测定特定前列腺抗原的血液水平、直肠指检和经直肠超声检查诊断前列腺癌
Actas Urol Esp. 1993 Jun;17(6):341-5; discussion 345-6.